Why Avenacy’s 27th injectable launch could matter more than its modest market size suggests
Injectable safety is becoming a workflow battle. Avenacy’s tranexamic acid launch tests demand for ready-to-use hospital formats.
Why BD’s Wellstar partnership could reshape medication delivery inside hospitals
Hospitals need safer medication delivery, not more disconnected tech. BD and Wellstar are testing whether AI can close that workflow gap.
What the Nexus Pharmaceuticals cyclophosphamide launch reveals about competition in sterile generic oncology drugs
Nexus Pharmaceuticals has launched cyclophosphamide injection in ready-to-dilute vials. Read what this means for oncology workflows and generic drug access.